Keyphrases
Left Ventricular Assist Device
72%
Heart Failure
45%
Dilated Cardiomyopathy
30%
Continuous-flow Left Ventricular Assist Device (CF-LVAD)
30%
Acute Decompensated Heart Failure
29%
Cardiac Transplantation
27%
Peripartum Cardiomyopathy
26%
Patients with Heart Failure
24%
Heart Failure Patients
21%
HeartMate II
20%
Heart Transplantation
20%
Transplantation
18%
Exercise Training
17%
Hazard Ratio
16%
Confidence Interval
16%
Left Ventricular Function
16%
Clinical Outcomes
15%
Left Ventricular Assist Device Implantation
13%
Mechanical Circulatory Support
13%
Left Ventricular Ejection Fraction
13%
Antibody-mediated Rejection
12%
Destination Therapy
12%
Quality of Life
12%
Precision Medicine
11%
Single Center
11%
Heart Transplant Recipients
11%
Magnetically Levitated
11%
Proband
11%
Bridge to Transplantation
10%
Orthotopic Heart Transplantation
10%
Heart Transplant
10%
Centrifugal Flow
10%
Left Ventricular Assist Device Support
10%
First-degree Relatives
10%
Clinical Course
10%
Cardiac Allograft
9%
VO2peak
9%
Cardiac Allograft Vasculopathy
9%
Pump Thrombosis
9%
Risk Factors
8%
Medical Therapy
8%
Human Heart
8%
Hospitalization
8%
Soluble Fibrin
8%
Gene Expression Profiling
8%
Driveline
8%
Multi-parameter
8%
Bleeding
8%
Pregnancy-associated Cardiomyopathy
8%
Axial-flow Pump
7%
Medicine and Dentistry
Left Ventricular Assist Device
100%
Congestive Heart Failure
82%
Heart Transplantation
37%
Heart Graft
31%
Peripartum Cardiomyopathy
20%
Apoplexy
16%
Dilated Cardiomyopathy
16%
Quality of Life
16%
Assisted Circulation
16%
Hazard Ratio
14%
Myocardial Disease
13%
Antibody Mediated Rejection
12%
Ventricular Assist Device
12%
Cardiac Allograft Vasculopathy
12%
Thrombosis
11%
Combination Therapy
11%
Allograft
11%
Heart Left Ventricle Ejection Fraction
11%
Infection
10%
Adverse Event
9%
Gene Expression Profiling
8%
Implant
8%
Driveline Infection
7%
Blood Pressure
7%
Acute Graft Rejection
7%
Orthotopic Heart Transplantation
7%
Diseases
7%
Device Therapy
7%
Outpatient
7%
Reoperation
7%
Cardiogenic Shock
6%
Bleeding
6%
Remote Patient Monitoring
6%
Clinical Trial
6%
Hemodynamic
5%
Human Leukocyte Antigen
5%
Cardiovascular System
5%
Ejection Fraction
5%
Heart Ventricle Remodeling
5%
Cancer
5%
Single-Photon Emission Computed Tomography
5%
Technetium-99
5%
Degree Relative
5%
Body Mass Index
5%
Prevalence
5%
Heart Muscle Ischemia
5%
Anticoagulation
5%
All Cause Mortality
5%
Gene Expression
5%